布鲁顿酪氨酸激酶及其抑制剂研究进展(5)
[20] Kil LP， de Bruijn MJ， van Hulst JA， et al. Bruton’s tyrosine kinase mediated signaling enhances leukemogenesis in a mouse model for chronic lymphocytic leukemia [J]. Am J Blood Res， 2013， 3(1)： 71-83.[21] de Rooij MF， Kuil A， Geest CR， et al. The clinically active BTK inhibitor PCI-32765 targets B-cell receptor- and chemokine-controlled adhesion and migration in chronic lymphocytic leukemia [J]. Blood ......
您现在查看是摘要页，全文长 2586 字符。